Biological Sample Kits Market

Global Biological Sample Collection Kits Market Size - By Product, By Application, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2035

Published: May-2026	Report ID: HLCA2616	Pages: 1 - 250	Formats^*:
Category : Healthcare

According to SPER Market Research, the Global Biological Sample Collection Kits Market is estimated to reach USD 21.34 billion by 2035 with a CAGR 7.95%.

Introduction and Overview

The report includes an in-depth analysis of the Global Biological Sample Collection Kits Market, including market size and trends, product mix, Applications, and supplier analysis.

The global Biological Sample Collection Kits Market was valued at USD 9.93 billion in 2025 and is projected to grow at a CAGR of 7.95% during the forecast period. Market growth is being supported by the increasing demand for accurate diagnostic testing, the rising prevalence of chronic and infectious diseases, and the expanding use of advanced sample collection technologies across healthcare settings. The growing focus on early disease detection, preventive healthcare, and personalized medicine is further contributing to the adoption of biological sample collection kits worldwide.

By Application

Based on application, the market is categorized into diagnostics and research. The diagnostics segment accounts for the largest share of the market as healthcare providers continue to rely heavily on timely and accurate testing for disease detection and patient monitoring. The increasing use of molecular diagnostics, automated testing systems, and minimally invasive collection methods has strengthened demand in this segment. In addition, the rising burden of chronic illnesses and infectious diseases continues to increase testing volumes globally.

By Product

By product type, the market includes swabs, blood and urine collection kits, viral transport media, and other related products. Blood and urine collection kits currently hold a dominant position in the market because they are widely used in routine diagnostics, health screening, disease monitoring, and laboratory analysis. The growing number of patients undergoing regular testing for diabetes, cardiovascular conditions, and other chronic diseases continues to support segment growth.

By End Use

Based on end use, the market is segmented into hospitals and clinics, diagnostic centers, home care settings, and others. Hospitals and clinics represent the leading segment owing to high patient footfall, frequent diagnostic procedures, and strong adoption of advanced laboratory technologies. These healthcare facilities require reliable and contamination-free sample collection systems to ensure testing accuracy and patient safety.

Regional Insights

North America continues to dominate the biological sample collection kits market, supported by its well-established healthcare infrastructure, strong presence of leading diagnostic companies, and rapid adoption of advanced testing technologies. The region also benefits from high healthcare spending and increasing demand for molecular diagnostics, genomics, and personalized medicine solutions.

Europe maintains a stable market position due to supportive healthcare policies, strict quality standards, and growing emphasis on preventive diagnostics. Countries such as Germany play an important role in regional market growth through strong research activities and advanced laboratory capabilities.

Meanwhile, the Asia Pacific region is emerging as a high-growth market due to improving healthcare access, rising awareness about early disease detection, increasing healthcare investments, and growing adoption of modern diagnostic technologies. Expanding healthcare infrastructure in developing economies is also creating new opportunities for market participants.

Market Competitive Landscape:

The Global Biological Sample Collection Kits Market is highly consolidated. Some of the market key players are Abbott, Altona Diagnostics, Becton, Dickinson and Company (BD), CTK Biotech, Hardy Diagnostics, HiMedia Laboratories, Labcorp, Lucence Health, Miraclean Technology, Puritan Medical, QIAGEN, Roche, Thermo Fisher Scientific

Recent Developments:

In June 2022, altona Diagnostics GmbH launched the RealStar Zoonotic Orthopoxvirus PCR Kit, strengthening its diagnostics portfolio and market position.
In May 2022, Labcorp introduced a home collection kit for diabetes that measures HbA1c using a small blood sample, enhancing convenience, supporting patient engagement, and reinforcing its position in home-based diagnostic testing.

Scope of the report:

Report Metric	Details
Market size available for years	2021-2034
Base year considered	2024
Forecast period	2025-2034
Segments covered	By Product, By Application, By End Use
Regions covered	North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Companies Covered	Abbott, Altona Diagnostics, Becton, Dickinson and Company (BD), CTK Biotech, Hardy Diagnostics, HiMedia Laboratories, Labcorp, Lucence Health, Miraclean Technology, Puritan Medical, QIAGEN, Roche, Thermo Fisher Scientific

Key Topics Covered in the Report

Global Biological Sample Collection Kits Market Size (FY’2022-FY’2035)
Overview of Global Biological Sample Collection Kits Market
Segmentation of Global Biological Sample Collection Kits Market by Product (Blood collection kits, Urine collection kits, Swabs, Viral transport media, Other products)
Segmentation of the Global Biological Sample Collection Kits Market by Application (Diagnostics, Research)
Segmentation of Global Biological Sample Collection Kits Market by End Use (Hospitals and clinics, Diagnostic centers, Homecare, Other end use)
Statistical Snap of Global Biological Sample Collection Kits Market
Expansion Analysis of Global Biological Sample Collection Kits Market
Problems and Obstacles in the Global Biological Sample Collection Kits Market
Competitive Landscape in the Global Biological Sample Collection Kits Market
Details on Current Investment in the Global Biological Sample Collection Kits Market
Competitive Analysis of the Global Biological Sample Collection Kits Market
Prominent Players in the Global Biological Sample Collection Kits Market
SWOT Analysis of Global Biological Sample Collection Kits Market
Global Biological Sample Collection Kits Market Future Outlook and Projections (FY’2026-FY’2035)
Recommendations from Analyst

1. Introduction

1.1 Scope of the report
1.2 Market segment analysis

2. Research Methodology

2.1 Research data source

2.1.1 Secondary Data
2.1.2 Primary Data
2.1.3 SPER’s internal Database
2.1.4 Primary insight from KOL’s

2.2 Market size estimation

2.2.1 Top-down and Bottom-up approach

2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

4.1 Driver, Restraint, Opportunity and Challenges analysis

4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges

5. Market variable and outlook

5.1 SWOT Analysis

5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats

5.2 PESTEL Analysis

5.2.1 Political Landscape
5.2.2 Economic Landscape
5.2.3 Social Landscape
5.2.4 Technological Landscape
5.2.5 Environmental Landscape
5.2.6 Legal Landscape

5.3 PORTER’s Five Forces
5.4 Heat Map Analysis

6. Competitive Landscape

6.1. Global Biological Sample Collection Kits Market Manufacturing Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Biological Sample Collection Kits Market

7. Global Biological Sample Collection Kits Market, By Product, (USD Million) 2022-2035

7.1 Blood collection kits
7.2 Urine collection kits
7.3 Swabs
7.3.1 Nasopharyngeal (NP) swabs
7.3.2 Oropharyngeal (OP) swabs
7.3.3 Nasal swabs
7.4 Viral transport media
7.5 Other products

8. Global Biological Sample Collection Kits Market, By Application, (USD Million) 2022-2035

8.1 Diagnostics
8.2 Research

9. Global Biological Sample Collection Kits Market, By End Use, (USD Million) 2022-2035

9.1 Hospitals and clinics
9.2 Diagnostic centers
9.3 Homecare
9.4 Other end use

10. Global Biological Sample Collection Kits Market, (USD Million) 2022-2035

10.1 Global Biological Sample Collection Kits Market Size and Market Share

11. Global Biological Sample Collection Kits Market, By Region, 2022-2035 (USD Million)

11.1 Asia-Pacific
11.1.1 Australia
11.1.2 China
11.1.3 India
11.1.4 Japan
11.1.5 South Korea
11.1.6 Rest of Asia-Pacific
11.2 Europe

11.2.1 France
11.2.2 Germany
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Rest of Europe

11.3 Middle East and Africa

11.3.1 Kingdom of Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Qatar
11.3.4 South Africa
11.3.5 Egypt
11.3.6 Morocco
11.3.7 Nigeria
11.3.8 Rest of Middle-East and Africa

11.4 North America

11.4.1 Canada
11.4.2 Mexico
11.4.3 United States

11.5 Latin America

11.5.1 Argentina
11.5.2 Brazil
11.5.3 Rest of America

12. Company Profile

12.1 Abbott

12.1.1 Company details
12.1.2 Financial outlook
12.1.3 Product summary
12.1.4 Recent developments

12.2 Altona Diagnostics

12.2.1 Company details
12.2.2 Financial outlook
12.2.3 Product summary
12.2.4 Recent developments

12.3 Becton, Dickinson and Company (BD)

12.3.1 Company details
12.3.2 Financial outlook
12.3.3 Product summary
12.3.4 Recent developments

12.4 CTK Biotech

12.4.1 Company details
12.4.2 Financial outlook
12.4.3 Product summary
12.4.4 Recent developments

12.5 Hardy Diagnostics

12.5.1 Company details
12.5.2 Financial outlook
12.5.3 Product summary
12.5.4 Recent developments

12.6 HiMedia Laboratories

12.6.1 Company details
12.6.2 Financial outlook
12.6.3 Product summary
12.6.4 Recent developments

12.7 Labcorp

12.7.1 Company details
12.7.2 Financial outlook
12.7.3 Product summary
12.7.4 Recent developments

12.8 Lucence Health

12.8.1 Company details
12.8.2 Financial outlook
12.8.3 Product summary
12.8.4 Recent developments

12.9 Miraclean Technology

12.9.1 Company details
12.9.2 Financial outlook
12.9.3 Product summary
12.9.4 Recent developments

12.10 Puritan Medical

12.10.1 Company details
12.10.2 Financial outlook
12.10.3 Product summary
12.10.4 Recent developments

12.11 QIAGEN

12.11.1 Company details
12.11.2 Financial outlook
12.11.3 Product summary
12.11.4 Recent developments

12.12 Roche

12.12.1 Company details
12.12.2 Financial outlook
12.12.3 Product summary
12.12.4 Recent developments

12.13 Thermo Fisher Scientific

12.13.1 Company details
12.13.2 Financial outlook
12.13.3 Product summary
12.13.4 Recent developments

12.14 Others

13. Conclusion

14. List Of Abbreviations

15. Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1